处方药量监管的探讨  

Discussion of the Prescription Dosage Management

作　　者：焦卫平[1] 

机构地区：[1]首都医科大学宣武医院,北京市100053

出　　处：《中国病案》2014年第12期19-20,共2页Chinese Medical Record

摘　　要：处方开药量在医政及医保管理都有相关的规定,但在临床工作中仍面临诸多未能详尽阐明的问题。医疗保险处于费用控制需要,对10种特殊疾病做出了可开出不超过1个月的可操作的具体规定,但多年未进一步进行疾病增补和完善。同时,由于医保在控制费用中片面强调单次开药量的网络审核和控制,卫生行政部门又疏于医疗行为的监控,给患者、医师和医院管理都带来一系列的现实难题。面对目前医保资源的不合理消耗及药品使用的不规范现象,医保和医政管理应做好顶层设计,从基本医保药品目录管理以及医师和参保人医疗行为规范等方面入手,加强对患者个体异常费用整体监控,注重临床医师的职业素养和道德规范教育,医政和医保分工合作,各司其职,才能真正合理高效的利用好医保资源,合理施治,实现医、患、保三方共赢。The dosage of each prescription have the respective regulations on the medical administration and medial insurance, but clinicians were always had puzzle about it in practice. To control the fee, the medial insurance have put into effect that ten diseases such as hypertension could prescribe dosage no more than 1 month, which is detailed and operability, but the list have not been increased and improved. The department of health care has partly lay stress on the scan in network and control of the dosage of each prescription, and the department of health administration have not supervisory control after years neglect, and that all cause a series of issues. Facing the irregular medical supply and the waste of medical resource, the medical administration and medical insurance should be cooperation about the overall situation, and regulate the contents of basic drugs and restrict the conducts of the clinicians or the patients, which it can be obtain the wins of the hospitals and the patients and medical insurance.

关 键 词：处方管理 医疗保险 开药量 

分 类 号：R95[医药卫生—药学]